杠杆资金连续12日加仓创业板股

Core Insights - The financing balance of the ChiNext board has reached 451.85 billion yuan, marking a continuous increase for 12 trading days, with a total increase of 51.62 billion yuan during this period [1][2]. Financing Balance Overview - As of August 26, 2025, the total margin balance of the ChiNext board is 453.31 billion yuan, with a day-on-day increase of 4.88 billion yuan. The financing balance specifically is 451.85 billion yuan, which is an increase of 4.88 billion yuan from the previous day [1][2]. - The financing balance has increased for 12 consecutive trading days, accumulating a total increase of 51.62 billion yuan [1]. Individual Stock Performance - During the period of increasing financing balance, 660 stocks saw an increase, with 259 stocks experiencing an increase of over 20%. The stock with the highest increase in financing balance is Meihua Medical, which saw an increase of 280.81% to a latest balance of 29.51 million yuan [2][3]. - Conversely, 283 stocks experienced a decrease in financing balance, with 26 stocks seeing a decline of over 20%. The largest decrease was observed in Kailong High-Tech, which saw a decline of 53.19% to a balance of 3.71 million yuan [2][3]. Sector Analysis - The stocks with financing balance increases of over 20% are primarily concentrated in the electronics, machinery equipment, and power equipment sectors, with 43, 38, and 31 stocks respectively [4]. Market Performance - Stocks with financing balance increases of over 20% averaged a rise of 16.03%, underperforming compared to the ChiNext index. The top performers include Oulu Tong, Zhinan Zhen, and Guangku Technology, with increases of 83.53%, 81.86%, and 61.61% respectively [5]. - The largest increase in financing balance by amount was Victory Technology, with a latest balance of 9.36 billion yuan, increasing by 3.46 billion yuan. Other notable increases include Xinyi Sheng, Zhongji Xuchuang, and Dongfang Caifu, with increases of 3.31 billion yuan, 2.66 billion yuan, and 2.26 billion yuan respectively [5].